Far From \u27Easy\u27 Spectroscopy with the 8π and GRIFFIN Spectrometers at TRIUMF-ISAC

The 8π spectrometer, installed at the TRIUMF-ISAC facility, was the world\u27s most sensitive γ-ray spectrometer dedicated to β-decay studies. A description is given of the 8π spectrometer and its auxiliary detectors including the plastic scintillator array SCEPTAR used for β-particle tagging and the Si(Li) array PACES for conversion electron measurements, its moving tape collector, and its data acquisition system. The recent investigation of the decay of 124Cs to study the nuclear structure of 124Xe, and how the β-decay measurements complemented previous Coulomb excitation studies, is highlighted, including the extraction of the deformation parameters for the excited 0+ bands in 124Xe. As a by-product, the decay scheme of the (7+) 124Cs isomeric state, for which the data from the PACES detectors were vital, was studied. Finally, a description of the new GRIFFIN spectrometer, which uses the same auxiliary detectors as the 8π spectrometer, is given

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

PURPOSE: Patients with acute myeloid leukemia with high-risk cytogenetics in first complete remission (CR1) achieve better outcomes if they undergo allogeneic hematopoietic cell transplantation (HCT) compared with consolidation chemotherapy alone. However, only approximately 40% of such patients typically proceed to HCT. METHODS: We used a prospective organized approach to rapidly identify donors to improve the allogeneic HCT rate in adults with high-risk acute myeloid leukemia in CR1. Newly diagnosed patients had cytogenetics obtained at enrollment, and those with high-risk cytogenetics underwent expedited HLA typing and were encouraged to be referred for consultation with a transplantation team with the goal of conducting an allogeneic HCT in CR1. RESULTS: Of 738 eligible patients (median age, 49 years; range, 18-60 years of age), 159 (22%) had high-risk cytogenetics and 107 of these patients (67%) achieved CR1. Seventy (65%) of the high-risk patients underwent transplantation in CR1 (P \u3c .001 compared with the historical rate of 40%). Median time to HCT from CR1 was 77 days (range, 20-356 days). In landmark analysis, overall survival (OS) among patients who underwent transplantation was significantly better compared with that of patients who did not undergo transplantation (2-year OS, 48% v 35%, respectively [P = .031]). Median relapse-free survival after transplantation in the high-risk cohort who underwent transplantation in CR1 (n = 70) was 11.5 months (range, 4-47 months), and median OS after transplantation was 14 months (range, 4-44 months). CONCLUSION: Early cytogenetic testing with an organized effort to identify a suitable allogeneic HCT donor led to a CR1 transplantation rate of 65% in the high-risk group, which, in turn, led to an improvement in OS when compared with the OS of patients who did not undergo transplantation

High-Statistics β\u3csup\u3e+\u3c/sup\u3e/EC-Decay Study of \u3csup\u3e122\u3c/sup\u3eXe

Low-lying excited states of 122Xe have been studied via the β+/EC decay of 122Cs with the 8π γ-ray spectrometer at the TRIUMF Isotope Separator and Accelerator facility. The data collected have enabled the observation of new in-band transitions in the excited 0+ state bands. In addition, the 2+ members of the second 0+ and third 0+ state bands have been firmly confirmed by angular correlation analysis